<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia - de Jong, PG - 2014 | Cochrane Library</title> <meta content="Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia - de Jong, PG - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004734.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia - de Jong, PG - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004734.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004734.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia" name="citation_title"/> <meta content="Paulien G de Jong" name="citation_author"/> <meta content="Academic Medical Center" name="citation_author_institution"/> <meta content="P.G.deJong@amc.uva.nl" name="citation_author_email"/> <meta content="Stef Kaandorp" name="citation_author"/> <meta content="Westfriesgasthuis" name="citation_author_institution"/> <meta content="Marcello Di Nisio" name="citation_author"/> <meta content="Mariëtte Goddijn" name="citation_author"/> <meta content="Academic Medical Center University of Amsterdam" name="citation_author_institution"/> <meta content="Saskia Middeldorp" name="citation_author"/> <meta content="Academic Medical Center" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD004734.pub4" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/07/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004734.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004734.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004734.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Abortion, Habitual [blood, etiology, *prevention &amp; control]; Anticoagulants [*therapeutic use]; Antiphospholipid Syndrome [complications]; Aspirin [therapeutic use]; Enoxaparin [therapeutic use]; Heparin, Low‐Molecular‐Weight [therapeutic use]; Live Birth; Nadroparin [therapeutic use]; Pregnancy Complications, Hematologic [*drug therapy, etiology]; Randomized Controlled Trials as Topic; Thrombophilia [complications, *drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004734.pub4&amp;doi=10.1002/14651858.CD004734.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="jU9oKp1Y";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004734\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004734\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004734.pub4",title:"Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia",firstPublishedDate:"Jul 4, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004734.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004734.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004734.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004734.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004734.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004734.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004734.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004734.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004734.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004734.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9113 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004734.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#CD004734-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#CD004734-sec-0088"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#CD004734-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#CD004734-sec-0033"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#CD004734-sec-0034"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#CD004734-sec-0069"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#CD004734-sec-0087"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/appendices#CD004734-sec-0093"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/table_n/CD004734StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/table_n/CD004734StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information#CD004734-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Paulien G de Jong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information#CD004734-cr-0003">Stef Kaandorp</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information#CD004734-cr-0004">Marcello Di Nisio</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information#CD004734-cr-0005">Mariëtte Goddijn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information#CD004734-cr-0006">Saskia Middeldorp</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information/en#CD004734-sec-0104">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 July 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004734.pub4">https://doi.org/10.1002/14651858.CD004734.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004734-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004734-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004734-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004734-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004734-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004734-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004734-abs-0001" lang="en"> <section id="CD004734-sec-0001"> <h3 class="title" id="CD004734-sec-0001">Background</h3> <p>Since hypercoagulability might result in recurrent miscarriage, anticoagulant agents could potentially increase the chance of live birth in subsequent pregnancies in women with unexplained recurrent miscarriage, with or without inherited thrombophilia. </p> </section> <section id="CD004734-sec-0002"> <h3 class="title" id="CD004734-sec-0002">Objectives</h3> <p>To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia. </p> </section> <section id="CD004734-sec-0003"> <h3 class="title" id="CD004734-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (1 October 2013) and scanned bibliographies of all located articles for any unidentified articles. </p> </section> <section id="CD004734-sec-0004"> <h3 class="title" id="CD004734-sec-0004">Selection criteria</h3> <p>Randomised and quasi‐randomised controlled trials that assessed the effect of anticoagulant treatment on live birth in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia were eligible. Interventions included aspirin, unfractionated heparin (UFH), and low molecular weight heparin (LMWH) for the prevention of miscarriage. One treatment could be compared with another or with no‐treatment (or placebo). </p> </section> <section id="CD004734-sec-0005"> <h3 class="title" id="CD004734-sec-0005">Data collection and analysis</h3> <p>Two review authors (PJ and SK) assessed the studies for inclusion in the review and extracted the data. If necessary they contacted study authors for more information. We double checked the data. </p> </section> <section id="CD004734-sec-0006"> <h3 class="title" id="CD004734-sec-0006">Main results</h3> <p>Nine studies, including data of 1228 women, were included in the review evaluating the effect of either LMWH (enoxaparin or nadroparin in varying doses) or aspirin or a combination of both, on the chance of live birth in women with recurrent miscarriage, with or without inherited thrombophilia. Studies were heterogeneous with regard to study design and treatment regimen and three studies were considered to be at high risk of bias. Two of these three studies at high risk of bias showed a benefit of one treatment over the other, but in sensitivity analyses (in which studies at high risk of bias were excluded) anticoagulants did not have a beneficial effect on live birth, regardless of which anticoagulant was evaluated (risk ratio (RR) for live birth in women who received aspirin compared to placebo 0.94, (95% confidence interval (CI) 0.80 to 1.11, n = 256), in women who received LMWH compared to aspirin RR 1.08 (95% CI 0.93 to 1.26, n = 239), and in women who received LMWH and aspirin compared to no‐treatment RR 1.01 (95% CI 0.87 to 1.16) n = 322). </p> <p>Obstetric complications such as preterm delivery, pre‐eclampsia, intrauterine growth restriction and congenital malformations were not significantly affected by any treatment regimen. In included studies, aspirin did not increase the risk of bleeding, but treatment with LWMH and aspirin increased the risk of bleeding significantly in one study. Local skin reactions (pain, itching, swelling) to injection of LMWH were reported in almost 40% of patients in the same study. </p> </section> <section id="CD004734-sec-0007"> <h3 class="title" id="CD004734-sec-0007">Authors' conclusions</h3> <p>There is a limited number of studies on the efficacy and safety of aspirin and heparin in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia. Of the nine reviewed studies quality varied, different treatments were studied and of the studies at low risk of bias only one was placebo‐controlled. No beneficial effect of anticoagulants in studies at low risk of bias was found. Therefore, this review does not support the use of anticoagulants in women with unexplained recurrent miscarriage. The effect of anticoagulants in women with unexplained recurrent miscarriage and inherited thrombophilia needs to be assessed in further randomised controlled trials; at present there is no evidence of a beneficial effect. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004734-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004734-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004734-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004734-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004734-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004734-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004734-abs-0004" lang="en"> <h3>Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia </h3> <p>Recurrent miscarriage is associated with inherited blood clotting disorders that could interfere with the placental blood circulation. Recurrent miscarriage can also be unexplained, with no known cause. Anticoagulant drugs such as aspirin or low molecular weight heparin may help women with recurrent miscarriage and such an underlying blood clotting problem. These drugs may also cause bleeding (including nose bleeds and haematomas) in the mother, though not in the baby. Data from nine included randomised controlled trials (involving 1228 women) analysed in this review, provided no evidence to support the use of anticoagulants in women with recurrent miscarriage, regardless of the presence of inherited blood clotting disorders (thrombophilia). </p> <p>Irrespective of the type or combination of anticoagulant, no benefit of anticoagulant treatment was found for live births. Obstetric complications were not clearly affected by any treatment regimen. Injection of low molecular weight heparin caused local skin reactions (pain, itching, swelling) in one study (side effects were not regularly reported in all studies). In the nine reviewed studies quality varied and different treatments were studied. Three studies were considered at high risk of bias. The number of studies on this topic remains limited. </p> <p>Thrombophilia refers to blood clotting disorders associated with a predisposition to thrombosis and thus increased risk for thrombotic events. It can be inherited as well as acquired, as is the case in the antiphospholipid syndrome. Both inherited and acquired thrombophilia are associated with vascular thrombosis as well as pregnancy complications including recurrent miscarriage and premature delivery. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004734-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004734-sec-0088"></div> <h3 class="title" id="CD004734-sec-0089">Implications for practice</h3> <section id="CD004734-sec-0089"> <p>Evidence on the efficacy and safety of aspirin and low molecular weight heparin (LMWH) in women with a history of at least two miscarriages without apparent risk factors other than inherited thrombophilia is limited, but now includes several high‐quality randomised controlled trials. Based on the results of the (pooled) analyses in this review, there is no evidence to support the use of anticoagulants in women with recurrent miscarriage (RM), regardless of the presence of inherited thrombophilia. Large randomised controlled trials assessing an effect of anticoagulants in women with RM and inherited thrombophilia are urgently needed. </p> </section> <h3 class="title" id="CD004734-sec-0090">Implications for research</h3> <section id="CD004734-sec-0090"> <p>Although several studies included women with inherited thrombophilia, subgroup analyses were never sufficiently powered to assess an effect of anticoagulation in these women with RM. We can not exclude a beneficial effect in these women and therefore, large randomised trials are urgently needed and because of a counterbalancing effect of heparin and aspirin, a placebo or no intervention arm is necessary, since it would provide an adequate control to the active treatment and allows assessing a risk‐benefit ratio. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004734-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004734-sec-0029"></div> <section id="CD004734-sec-0030"> <h3 class="title" id="CD004734-sec-0030">Description of the condition</h3> <p>Up to 15% of all clinically recognised pregnancies end in miscarriage (miscarriage before the 20th week of gestational age) (<a href="./references#CD004734-bbs2-0048" title="EverettC . Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ1997;315:32‐4. ">Everett 1997</a>; <a href="./references#CD004734-bbs2-0055" title="HuisjesHJ . Spontaneous Abortion. London: Churchill Livingstone, 1984:6. ">Huisjes 1984</a>). Approximately 5% of women experience two or more miscarriages (recurrent miscarriage, RM), whereas three or more first trimester miscarriages may affect as many as 1% to 2% of women of reproductive age (<a href="./references#CD004734-bbs2-0043" title="CliffordK , RaiR , WatsonH , ReganL . An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Human Reproduction1994;9:1328‐32. ">Clifford 1994</a>; <a href="./references#CD004734-bbs2-0045" title="CookCL , PridmanDD . Recurrent pregnancy loss. Current Opinion in Obstetrics and Gynecology1995;7:357‐66. ">Cook 1995</a>; <a href="./references#CD004734-bbs2-0086" title="StirratGM . Recurrent miscarriage: definition and epidemiology. Lancet1990;336:673‐5. ">Stirrat 1990</a>). RM is devastating for women and their families. The definition of RM remains a subject of debate. The World Health Organization (WHO) defines miscarriage as the spontaneous loss of a clinical pregnancy that occurs before 20 completed weeks of gestational age (<a href="./references#CD004734-bbs2-0090" title="Zegers‐HochschildF , AdamsonGD , deMouzonJ , IshiharaO , MansourR , NygrenK , et al. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Human Reproduction (Oxford, England)2009;24(11):2683‐7. [PUBMED: 19801627] ">WHO 2009</a>). Often RM is defined as three or more consecutive miscarriages. According to recent European Society for Human Reproduction &amp; Embryology (ESHRE) guidelines, RM is traditionally defined as three or more consecutive miscarriages occurring before 20 weeks' gestation (<a href="./references#CD004734-bbs2-0058" title="JauniauxE , FarquharsonRG , ChristiansenOB , ExaltoN . Evidence‐based guidelines for the investigation and medical treatment of recurrent miscarriage. Human Reproduction2006;21:2216‐22. ">Jauniaux 2006</a>). Recent evidence shows that two miscarriages constitute RM (<a href="./references#CD004734-bbs2-0037" title="BhattacharyaS , TownendJ , BhattacharyaS . Recurrent miscarriage: Are three miscarriages one too many? Analysis of a Scottish population‐based database of 151,021 pregnancies. European Journal of Obstetrics, Gynecology, and Reproductive Biology2010;150(1):24‐7. [PUBMED: 20207064] ">Bhattacharya 2010</a>; <a href="./references#CD004734-bbs2-0057" title="JaslowCR , CarneyJL , KuttehWH . Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertility and Sterility2010;93(4):1234‐43. [PUBMED: 19338986] ">Jaslow 2010</a>). Adequate characterisation of miscarriages and patients in RM studies is most important and, favourably, would make studies mutually comparable (<a href="./references#CD004734-bbs2-0042" title="ChristiansenOB . Evidence‐based investigations and treatments of recurrent pregnancy loss. Current Opinion in Obstetrics and Gynecology2006;18:304‐12. ">Christiansen 2006</a>). The risk of miscarriage after two or three consecutive miscarriages is similar (<a href="./references#CD004734-bbs2-0079" title="ReganL . A prospective study of spontaneous abortion. Early Pregnancy Loss: Mechanisms and Treatment. RCOG, 1988. ">Regan 1988</a>). </p> <p>Furthermore, the presence of parenteral chromosome abnormalities, which is a known risk factor for recurrent miscarriage (<a href="./references#CD004734-bbs2-0050" title="FranssenMT , KorevaarJC , LeschotNJ , BossuytPM , KnegtAC , Gerssen‐SchoorlKB , et al. Selective chromosome analysis in couples with two or more miscarriages: case‐control study. BMJ2005;331:137‐41. ">Franssen 2005</a>), as well as the presence of antiphospholipid antibodies, another known risk factor for recurrent miscarriage (<a href="./references#CD004734-bbs2-0058" title="JauniauxE , FarquharsonRG , ChristiansenOB , ExaltoN . Evidence‐based guidelines for the investigation and medical treatment of recurrent miscarriage. Human Reproduction2006;21:2216‐22. ">Jauniaux 2006</a>), are not different in women with two or three miscarriages (<a href="./references#CD004734-bbs2-0087" title="van denBoogaardE , KaandorpSP , FranssenMT , MolBW , LeschotNJ , WoutersCH , et al. Consecutive or non‐consecutive recurrent miscarriage: is there any difference in carrier status?. Human Reproduction (Oxford, England)2010;25(6):1411‐4. [PUBMED: 20382970] ">van den Boogaard 2010</a>; <a href="./references#CD004734-bbs2-0088" title="van denBoogaardE , CohnDM , KorevaarJC , DawoodF , VissenbergR , MiddeldorpS , et al. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage. Fertility and Sterility 2012 Oct 6 [Epub ahead of print]. [DOI: 10.1016/j.fertnstert.2012.09.002.] ">van den Boogaard 2012</a>). We therefore chose to use the broad definition of RM in this review: two or more not necessarily consecutive miscarriages. </p> <p>Miscarriage is associated with relevant maternal morbidity like bleeding and infection and, sometimes, maternal death (<a href="./references#CD004734-bbs2-0073" title="National Health and Medical Research Council. Report on Maternal Deaths in Australia 1994‐96. Canberra. Australian Institute of Health and Welfare National Perinatal Statistics Unit, 2001. ">NHMRC 2001</a>), particularly in low‐income countries (<a href="./references#CD004734-bbs2-0052" title="GoyauxN , AlihonouE , DiadhiouF , LekeR , ThonneauPF . Complications of induced abortion and miscarriage in three African Countries: a hospital‐based study among WHO collaborating centres. Acta Obstetricia et Gynecologica Scandinavica2001;80:568‐73. ">Goyaux 2001</a>). Moreover, miscarriage, especially if recurrent, might cause important psychological and emotional distress that can be further complicated by feelings of anxiety and depression as well as social withdrawal (<a href="./references#CD004734-bbs2-0062" title="LeeC , SladeP . Miscarriage as a traumatic event: a review of the literature and new implications for intervention. Journal of Psychosomatic Research1996;40(3):235‐44. ">Lee 1996</a>; <a href="./references#CD004734-bbs2-0067" title="LokIH , NeugebauerR . Psychological morbidity following miscarriage. Best Practice &amp; Research. Clinical Obstetrics &amp; Gynaecology2007;21(2):229‐47. [PUBMED: 17317322] ">Lok 2007</a>). </p> <p>Several factors may be involved in the aetiology of RM. Women experiencing RM may have an underlying medical condition such as carrier status of a structural chromosome abnormality (<a href="./references#CD004734-bbs2-0038" title="BraekeleerM , DaoTN . Cytogenetic studies in couples experiencing repeated pregnancy losses. Human Reproduction1990;5:519‐28. ">Braekeleer 1990</a>; <a href="./references#CD004734-bbs2-0050" title="FranssenMT , KorevaarJC , LeschotNJ , BossuytPM , KnegtAC , Gerssen‐SchoorlKB , et al. Selective chromosome analysis in couples with two or more miscarriages: case‐control study. BMJ2005;331:137‐41. ">Franssen 2005</a>), antiphospholipid syndrome, or other blood clotting disorders generally referred to as thrombophilias (<a href="./references#CD004734-bbs2-0082" title="RobertsonL , WuO , LanghorneP , TwaddleS , ClarkP , LoweGD , et al. Thrombophilia in pregnancy: a systematic review. British Journal of Haematology2006;132(2):171‐96. [PUBMED: 16398652] ">Robertson 2006</a>) or a septate uterus (<a href="./references#CD004734-bbs2-0040" title="ChanYY , JayaprakasanK , ZamoraJ , ThorntonJG , Raine‐FenningN , CoomarasamyA . The prevalence of congenital uterine anomalies in unselected and high‐risk populations: a systematic review. Human Reproduction Update2011;17(6):761‐71. [PUBMED: 21705770] ">Chan 2011</a>). Factors less strongly associated with RM are hyperhomocysteinemia and endocrine abnormalities (<a href="./references#CD004734-bbs2-0041" title="ChristiansenOB , Nybo AndersenAM , BoschE , DayaS , DelvesPJ , HviidTV , et al. Evidence‐based investigations and treatments of recurrent pregnancy loss. Fertility and Sterility2005;83(4):821‐39. ">Christiansen 2005</a>). </p> <p>Thrombophilia is a diverse group of coagulation disorders associated with a predisposition to thrombosis and thus increased risk for thrombotic events such as deep vein thrombosis and pulmonary embolism. These hypercoagulable states can either be inherited as the factor V Leiden mutation (which results in a decreased capacity to inactivate activated factor V by the protein C system, also known as activated protein C (APC) resistance), the deficiency of physiological anticoagulants like protein C, protein S and antithrombin and the prothrombin G20210A gene mutation (resulting in increased concentrations of prothrombin in plasma) or an elevated level of factor VIII‐ac (<a href="./references#CD004734-bbs2-0070" title="MiddeldorpS , LeviM . Thrombophilia: an update. Seminars in Thrombosis and Hemostasis2007;33(6):563‐72. [PUBMED: 17768688] ">Middeldorp 2007a</a>) or acquired, as for instance the antiphospholipid syndrome. In this latter syndrome, the predisposition to thrombosis is acquired due to the presence of antiphospholipid antibodies (<a href="./references#CD004734-bbs2-0064" title="LimW , CrowtherMA , EikelboomJW . Management of antiphospholipid antibody syndrome: a systematic review. JAMA2006;295(9):1050‐7. [PUBMED: 16507806] ">Lim 2006</a>). </p> <p>A growing body of evidence has implicated thrombophilia in adverse obstetrical events (such as intrauterine growth restriction, (recurrent) miscarriage, severe pre‐eclampsia, and placental abruption) (<a href="./references#CD004734-bbs2-0059" title="KupfermincMJ , EldorA , SteinmanN , ManyA , Bar‐AmA , JaffaA , et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. New England Journal of Medicine1999;340:9‐13. ">Kupferminc 1999</a>; <a href="./references#CD004734-bbs2-0069" title="MiddeldorpS . Thrombophilia and pregnancy complications: cause or association?. Journal of Thrombosis and Haemostasis2007;5 Suppl 1:276‐82. ">Middeldorp 2007</a>), and there is also reasonable evidence to suggest that some cases of RM are associated with thrombosis of placental vessels and infarction. Firstly, microthrombi are a common finding in the placental vasculature of women with RM (<a href="./references#CD004734-bbs2-0083" title="RushtonDI . Placental pathology in spontaneous miscarriage. In: BeardRW , SharpF editor(s). Early Pregnancy Loss: Mechanisms and Treatment. London: RCOG, 1988:149‐58. ">Rushton 1988</a>). Secondly, placental thrombosis and infarction have been described in association with certain thrombophilic defects (<a href="./references#CD004734-bbs2-0046" title="DizonTD , MelineL , NelsonLM , VarnerM , WardK . Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. American Journal of Obstetrics and Gynecology1997;177:402‐5. ">Dizon 1997</a>; <a href="./references#CD004734-bbs2-0077" title="RaiRS , ReganL , ChitolieA , DonaldJG , CohenH . Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. British Journal of Obstetrics and Gynaecology1996;103:842‐4. ">Rai 1996</a>), but other pathophysiological pathways than thrombosis could also be involved, since adverse pregnancy outcomes can occur in women with thrombophilia in the absence of placental thrombosis (<a href="./references#CD004734-bbs2-0072" title="MousaHA , AlfirevicZ . Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Human Reproduction2000;15:1830‐3. ">Mousa 2000</a>). Thirdly, thrombophilic defects are significantly more prevalent amongst women with such pregnancy complications (<a href="./references#CD004734-bbs2-0076" title="RaiRS , ReganL , CliffordK , PickeringW , DaveM , MackieI , et al. Antiphospholipid antibodies and beta2‐glycoprotein‐I in 500 women with recurrent miscarriage: results of a comprehensive approach. Human Reproduction1995;10:2001‐5. ">Rai 1995</a>; <a href="./references#CD004734-bbs2-0081" title="ReyE , KahnSR , DavidM , ShrierI . Thrombophilic disorders and fetal loss: a meta‐analysis. Lancet2003;361:901‐8. ">Rey 2003</a>). A meta‐analysis of population‐based studies showed that the magnitude of the association with thrombophilia varies according to the timing of fetal loss (<a href="./references#CD004734-bbs2-0081" title="ReyE , KahnSR , DavidM , ShrierI . Thrombophilic disorders and fetal loss: a meta‐analysis. Lancet2003;361:901‐8. ">Rey 2003</a>). In particular, first trimester RM was associated with factor V Leiden mutation, APC resistance, and prothrombin G20210A mutation, while late non‐recurrent fetal loss was associated with factor V Leiden mutation, prothrombin G20210A mutation, and protein S deficiency. Also, family studies showed that women with inherited thrombophilia, especially those with combined defects or antithrombin deficiency, have an increased risk of miscarriage and intrauterine fetal death compared to women without these defects (<a href="./references#CD004734-bbs2-0068" title="MeinardiJR , MiddeldorpS , deKamPJ , KoopmanMMW , vanPampusECM , HamulyakK , et al. Increased risk for fetal loss in carriers of the factor V Leiden. Annals of Internal Medicine1999;130:736‐9. ">Meinardi 1999</a>; <a href="./references#CD004734-bbs2-0075" title="PrestonF , RosendaalFR , WalkerID , BrietE , BerntorpE , ConardJ , et al. Increased fetal loss in women with heritable thrombophilia. Lancet1996;348:913‐6. ">Preston 1996</a>; <a href="./references#CD004734-bbs2-0084" title="SansonBJ , FriederichPW , SimioniP , ZanardiS , HuismanMV , GirolamiA , et al. The risk of abortion and stillbirth in antithrombin‐, protein C‐, and protein S‐deficient women. Thrombosis and Haemostasis1996;75(3):387‐8. ">Sanson 1996</a>). </p> <p>The antiphospholipid syndrome is an acquired thrombophilia and associated both with vascular thrombosis and pregnancy complications (including RM and premature delivery) (<a href="./references#CD004734-bbs2-0063" title="LevineJS , BranchW , RauchJ . The antiphospholipid syndrome. New England Journal of Medicine2002;346:752‐63. ">Levine 2002</a>). These adverse pregnancy outcomes may result from placental infarctions and thrombotic changes in decidual microvessels (<a href="./references#CD004734-bbs2-0056" title="Infante‐ReviardC , DavidM , GauthierR , RivardGE . Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case‐control study. New England Journal of Medicine1991;325:1063‐6. ">Infante‐Reviard 1991</a>; <a href="./references#CD004734-bbs2-0066" title="LockshinMD . Pregnancy loss in the antiphospholipid syndrome. Thrombosis and Haemostasis1999;82:641‐8. ">Lockshin 1999</a>). The use of antithrombotic agents heparin (unfractionated heparin or low‐molecular‐weight heparin (LMWH)) and aspirin has been studied in women with antiphospholipid syndrome. Both agents have anti‐clotting properties, but these work differently: heparin increases the effect of the natural anticoagulant antithrombin; whereas aspirin inhibits platelet aggregation. Heparin and aspirin seem to be effective and safe in reducing miscarriage rates in women with antiphospholipid syndrome with significantly better pregnancy outcome than aspirin alone (rate of live births of 71% to 80% versus 42% to 44% respectively, an absolute risk difference of 36%) (<a href="./references#CD004734-bbs2-0060" title="KuttehWH . Antiphospholipid antibody‐associated recurrent pregnancy loss: treatment with heparin and low‐dose aspirin is superior to low‐dose aspirin alone. American Journal of Obstetrics and Gynecology1996;174:1584‐9. ">Kutteh 1996</a>; <a href="./references#CD004734-bbs2-0078" title="RaiR , CohenH , DaveM , ReganL . Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ1997;314:253‐7. ">Rai 1997</a>), although findings have not always been consistent (<a href="./references#CD004734-bbs2-0049" title="FarquharsonRG , QuenbyS , GreavesM . Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics &amp; Gynecology2002;100:408‐13. ">Farquharson 2002</a>; <a href="./references#CD004734-bbs2-0061" title="LaskinCA , SpitzerKA , ClarkCA , CrowtherMR , GinsbergJS , HawkerGA , et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Journal of Rheumatology2009;36(2):279‐87. [PUBMED: 19208560] ">Laskin 2009</a>). Inconsistency in these study results may be explained by alternate treatment regimens, or the use of different diagnostic criteria, as these have been revised over time by consensus (<a href="./references#CD004734-bbs2-0071" title="MiyakisS , LockshinMD , AtsumiT , BranchDW , BreyRL , CerveraR , et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis2006;4(2):295‐306. [PUBMED: 16420554] ">Miyakis 2006</a>). Both the therapy for RM associated with the antiphospholipid syndrome and other possible therapies currently considered for the prevention of RM (as progesterone and immunotherapy) are the topics covered in other Cochrane reviews (<a href="./references#CD004734-bbs2-0047" title="EmpsonM , LassereM , CraigJ , ScottJ . Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD002859.pub2] ">Empson 2005</a>; <a href="./references#CD004734-bbs2-0053" title="HaasDM , RamseyPS . Progestogen for preventing miscarriage. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD003511.pub2] ">Haas 2008</a>; <a href="./references#CD004734-bbs2-0074" title="PorterTF , LaCoursiereY , ScottJR . Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD000112.pub2] ">Porter 2006</a>). </p> <p>Estimates of the prognosis of subsequent pregnancies in women with RM without antiphospholipid syndrome range from live birth rates of approximately 50% to 89% (<a href="./references#CD004734-bbs2-0039" title="BrighamSA , ConlonC , FarquharsonRG . A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Human Reproduction1999;14:2868‐71. ">Brigham 1999</a>; <a href="./references#CD004734-bbs2-0044" title="CohnDM , GoddijnM , MiddeldorpS , KorevaarJC , DawoodF , FarquharsonRG . Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. Journal of Thrombosis and Haemostasis2010;8(10):2208‐13. [PUBMED: 20704646] ">Cohn 2010</a>; <a href="./references#CD004734-bbs2-0065" title="LindqvistPG , MerloJ . The natural course of women with recurrent fetal loss. Journal of Thrombosis and Haemostasis2006;4:896‐7. ">Lindqvist 2006</a>; <a href="./references#CD004734-bbs2-0023" title="RaiR , BackosM , BaxterN , ChilcottI , ReganL . Recurrent miscarriage‐an aspirin a day?. Human Reproduction2000;15(10):2220‐3. ">Rai 2000</a>; <a href="./references#CD004734-bbs2-0086" title="StirratGM . Recurrent miscarriage: definition and epidemiology. Lancet1990;336:673‐5. ">Stirrat 1990</a>). For women with RM and underlying thrombophilic disorders, these figures range from 63% to 80% (<a href="./references#CD004734-bbs2-0075" title="PrestonF , RosendaalFR , WalkerID , BrietE , BerntorpE , ConardJ , et al. Increased fetal loss in women with heritable thrombophilia. Lancet1996;348:913‐6. ">Preston 1996</a>; <a href="./references#CD004734-bbs2-0023" title="RaiR , BackosM , BaxterN , ChilcottI , ReganL . Recurrent miscarriage‐an aspirin a day?. Human Reproduction2000;15(10):2220‐3. ">Rai 2000</a>). The differences between studies can probably be explained by differences in the populations of women participating in the studies. </p> </section> <section id="CD004734-sec-0031"> <h3 class="title" id="CD004734-sec-0031">Description of the intervention</h3> <p>The use of anticoagulants in pregnancy needs to be carefully evaluated for efficacy and safety since it can carry risks for the mother and the fetus. Coumarin derivatives are anticoagulant drugs used most often in case of thrombosis, but cross the placenta and can display teratogenic effects. In contrast to coumarin derivatives, neither UFH nor LMWH cross the placenta and therefore do not have the potential to cause fetal bleeding and teratogenicity (<a href="./references#CD004734-bbs2-0051" title="GinsbergJS , GreerI , HirshJ . Use of antithrombotic agents during pregnancy. Chest2001;119(Suppl):122‐31. ">Ginsberg 2001</a>). The maternal risks associated with heparin administration are uncommon but potentially serious and include bleeding, heparin‐induced thrombocytopenia and heparin‐induced osteopenia with fractures. Moreover, heparin administration may cause pain and slight bruising at injection sites. There is accumulating evidence that LMWH is at least as effective and safe as UFH with potential advantages during pregnancy, since they cause less heparin‐induced thrombocytopenia, can be administered once daily, and are associated with a lower risk of heparin‐induced osteoporosis (<a href="./references#CD004734-bbs2-0036" title="BatesSM , GreerIA , MiddeldorpS , VeenstraDL , PrabulosAM , VandvikPO . VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e691S‐736S. [PUBMED: 22315276] ">Bates 2012</a>; <a href="./references#CD004734-bbs2-0051" title="GinsbergJS , GreerI , HirshJ . Use of antithrombotic agents during pregnancy. Chest2001;119(Suppl):122‐31. ">Ginsberg 2001</a>; <a href="./references#CD004734-bbs2-0085" title="SansonBJ , LensingAW , PrinsMH , GinsbergJS , BarkaganZS , Lavenne‐PardongeE . Safety of low‐molecular‐weight heparin in pregnancy. A systematic review. Thrombosis and Haemostasis1999;81:668‐72. ">Sanson 1999</a>). Based on current evidence, aspirin (less than 150 mg/d) during the second and third trimesters appears to be safe, while the safety of higher doses of aspirin during the first trimester remains uncertain (<a href="./references#CD004734-bbs2-0035" title="AskieLM , DuleyL , Henderson‐SmartDJ , StewartLA . Antiplatelet agents for prevention of pre‐eclampsia: a meta‐analysis of individual patient data. Lancet2007;369(9575):1791‐8. [PUBMED: 17512048] ">Askie 2007</a>; <a href="./references#CD004734-bbs2-0036" title="BatesSM , GreerIA , MiddeldorpS , VeenstraDL , PrabulosAM , VandvikPO . VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e691S‐736S. [PUBMED: 22315276] ">Bates 2012</a>; <a href="./references#CD004734-bbs2-0051" title="GinsbergJS , GreerI , HirshJ . Use of antithrombotic agents during pregnancy. Chest2001;119(Suppl):122‐31. ">Ginsberg 2001</a>). The use of heparin in pregnancy has been covered in another Cochrane review (<a href="./references#CD004734-bbs2-0089" title="WalkerMC , FergusonSE , AllenVM . Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database of Systematic Reviews2003, Issue 2. [DOI: 10.1002/14651858.CD003580] ">Walker 2003</a>). </p> </section> <section id="CD004734-sec-0032"> <h3 class="title" id="CD004734-sec-0032">Why it is important to do this review</h3> <p>In clinical practice, women with RM associated with inherited thrombophilia or RM without any other apparent predisposing disorder are frequently seeking advice about the indication for anticoagulant treatment. Some clinicians tend to extrapolate the beneficial effect of anticoagulant therapy in women with antiphospholipid syndrome and RM to all women with RM. Whether there is evidence for an effect of anticoagulants in women with RM ‐ either unexplained or associated with inherited thrombophilia ‐ is the objective of this review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004734-sec-0033" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004734-sec-0033"></div> <p>The objective of this review was to determine whether anticoagulant treatment improves the chance of a live birth in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004734-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004734-sec-0034"></div> <section id="CD004734-sec-0035"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004734-sec-0036"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials and quasi‐randomised controlled trials that assessed the effect of anticoagulant treatment on improving the live birth rate in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia. </p> </section> <section id="CD004734-sec-0037"> <h4 class="title">Types of participants</h4> <p>Participants were pregnant women with a history of at least two unexplained miscarriages with or without inherited thrombophilia. Of studies that included women attempting to conceive, but who were not pregnant upon randomisation only results of women who became pregnant were included. Studies that included women with apparent risk factors (other than inherited thrombophilia) of RM (antiphospholipid syndrome; uterine abnormalities; patients' or their partners' karyotype abnormalities) were included only if the results from women with a history of at least two unexplained miscarriages with or without inherited thrombophilia could be extracted to be analysed separately. For this review, we selected studies in women with two or more previous miscarriages up to 24 weeks' gestation. The study populations are described whenever possible with regard to number of miscarriages, gestational age of the miscarriages, and maternal age. </p> </section> <section id="CD004734-sec-0038"> <h4 class="title">Types of interventions</h4> <p>The interventions included were aspirin, UFH, and LMWH for the prevention of miscarriage. One treatment could be compared with another or with no treatment (or placebo). Combinations of therapy could be used. To exclude a potential lack of efficacy due to a limited duration of treatment, only studies in which the investigational treatment was started at a maximum of 12 weeks' gestation and continued beyond 32 weeks' gestation or until the end of pregnancy were eligible. </p> </section> <section id="CD004734-sec-0039"> <h4 class="title">Types of outcome measures</h4> <section id="CD004734-sec-0040"> <h5 class="title">Primary outcomes</h5> <p>Live birth.</p> </section> <section id="CD004734-sec-0041"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004734-list-0001"> <li> <p>Preterm delivery of a live infant before 37 weeks' gestational age (not a prespecified outcome). </p> </li> <li> <p>Preterm delivery of a live infant between 24 and 28 weeks' gestational age.</p> </li> <li> <p>Preterm delivery of a live infant between 28 and 32 weeks' gestational age.</p> </li> <li> <p>Preterm delivery of a live infant between 32 and 37 weeks' gestational age.</p> </li> <li> <p>Obstetric complications (gestational hypertension, pre‐eclampsia, intrauterine growth restriction). </p> </li> <li> <p>Congenital malformations.</p> </li> <li> <p>Admission to special care.</p> </li> <li> <p>Side effects of the drug used, both for the mother and the baby (maternal and/or neonatal bleeding, heparin‐induced thrombocytopenia, heparin‐induced osteopenia, pain, itching or swelling at injection sites and allergic reactions to heparin). </p> </li> <li> <p>Thromboembolic complications.</p> </li> </ol> </p> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> </section> </section> </section> <section id="CD004734-sec-0042"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004734-sec-0043"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register by contacting the Trials Search Co‐ordinator (1 October 2013).  </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD004734-list-0002"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE;</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. </p> <p>For additional searching performed for the previous version of the review, please see <a href="./appendices#CD004734-sec-0094">Appendix 1</a>. </p> </section> <section id="CD004734-sec-0044"> <h4 class="title">Searching other resources</h4> <p>We scanned bibliographies of all located articles for further studies.</p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD004734-sec-0045"> <h3 class="title" id="CD004734-sec-0045">Data collection and analysis</h3> <p>For the methods used when assessing the trials identified in the previous version of this review, <i>see</i><a href="./appendices#CD004734-sec-0095">Appendix 2</a>. </p> <p>For this update we used the following methods when assessing the reports identified by the updated search. </p> <section id="CD004734-sec-0046"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted a third review author. </p> </section> <section id="CD004734-sec-0047"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted a third review author. We entered data into Review Manager software (<a href="./references#CD004734-bbs2-0080" title="The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> <p>Dr Kaandorp, Dr Goddijn, and Dr Middeldorp were investigators of the randomised controlled trial ALIFE study (<a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>) and so this trial was assessed by the other review authors. </p> </section> <section id="CD004734-sec-0048"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions (</i><a href="./references#CD004734-bbs2-0054" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a><i>).</i> We resolved any disagreement by discussion or by involving a third assessor. </p> <section id="CD004734-sec-0049"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD004734-list-0003"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004734-sec-0050"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD004734-list-0004"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.   </p> </li> </ul> </p> </section> <section id="CD004734-sec-0051"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>Performance bias and detection bias were not included as criterion for quality as we anticipated that the outcome live birth was not influenced by blinding. </p> </section> <section id="CD004734-sec-0052"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>Performance bias and detection bias were not included as criterion for quality as we anticipated that the outcome live birth was not influenced by blinding. </p> </section> <section id="CD004734-sec-0053"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.  Where sufficient information was reported, or could be supplied by the trial authors, we re‐included missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD004734-list-0005"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups; ≦ 20% participants missing); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation; more than 20% participants missing); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004734-sec-0054"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias. </p> <p>We assessed the methods as:</p> <p> <ul id="CD004734-list-0006"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004734-sec-0055"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we have about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD004734-list-0007"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD004734-sec-0056"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD004734-bbs2-0054" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses ‐ see <a href="#CD004734-sec-0068">Sensitivity analysis</a>.  </p> </section> </section> <section id="CD004734-sec-0057"> <h4 class="title">Measures of treatment effect</h4> <section id="CD004734-sec-0058"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.  </p> </section> <section id="CD004734-sec-0059"> <h5 class="title">Continuous data</h5> <p>We did not analyse any continuous data.</p> </section> </section> <section id="CD004734-sec-0060"> <h4 class="title">Unit of analysis issues</h4> <section id="CD004734-sec-0061"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials for inclusion in this review. In future updates, if identified and eligible, we will include cluster‐randomised trials in the analyses along with individually‐randomised trials. We will adjust their sample sizes using the methods described in the <i>Handbook</i> [Section 16.3.4 or 16.3.6] using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD004734-sec-0062"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials were excluded.</p> </section> </section> <section id="CD004734-sec-0063"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We planned to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. However, none of the included studies were considered to be at high risk of attrition bias. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. </p> </section> <section id="CD004734-sec-0064"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the T², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a T² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.<b> </b> </p> </section> <section id="CD004734-sec-0065"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD004734-sec-0066"> <h4 class="title">Data synthesis</h4> <p>Data were pooled based on type of intervention, but irrespective of the dose of LMWH or aspirin. Only studies in which the investigational treatment was started at a maximum of 12 weeks' gestation and continued beyond 32 weeks' gestation were included. </p> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD004734-bbs2-0080" title="The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average of the range of possible treatment effects and we planned to discuss the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. </p> <p>If we used random‐effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD004734-sec-0067"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we planned to investigate it using subgroup analyses and sensitivity analyses. We planned to consider whether an overall summary was meaningful, and if it was, use random‐effects analysis to produce it. </p> <p>We planned to carry out the following subgroup analyses:</p> <p> <ol id="CD004734-list-0008"> <li> <p>inherited thrombophilia versus no inherited thrombophilia;</p> </li> <li> <p>different inherited thrombophilic disorders;</p> </li> <li> <p>preconceptional versus periconceptional anticoagulant use;</p> </li> <li> <p>type of anticoagulant(s) used (e.g. single drug, combination of anticoagulant agents);</p> </li> <li> <p>dose of anticoagulant(s);</p> </li> <li> <p>duration of anticoagulant use;</p> </li> <li> <p>women with a history of three or more miscarriages;</p> </li> <li> <p>women with no previous live birth versus women with one or more previous live birth.</p> </li> </ol> </p> <p>We planned to use the primary outcome, live birth, in subgroup analyses. However, due to lack of data, we were not able to conduct planned subgroup analysis. We included data from single subgroups in the analysis of the primary outcome, but due to lack of data, we did not explore the treatment effect between the pre‐specified subgroups as outlined above. </p> <p>In future updates, if more data become available, we will assess subgroup differences by interaction tests available within RevMan (<a href="./references#CD004734-bbs2-0080" title="The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD004734-sec-0068"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses for the main outcomes by individual quality criteria to assess the effect of poorer quality studies on the magnitude of the estimate of effect. Only studies at an overall low risk of bias were included in the initial analyses and we carried out sensitivity analyses to explore the effect of quality. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004734-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004734-sec-0069"></div> <section id="CD004734-sec-0070"> <h3 class="title">Description of studies</h3> <section id="CD004734-sec-0071"> <h4 class="title">Included studies</h4> <p>Details for the studies included are in the <a href="./references#CD004734-sec-0107" title="">Characteristics of included studies</a>. </p> <p>We included nine studies (1228 women for the primary outcome live birth) (<a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a>; <a href="./references#CD004734-bbs2-0002" title="ClarkP . The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). ClarkP , WalkerID , LanghorneP , CrichtonL , ThomsonA , GreavesM , et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low‐molecular‐weight heparin and low‐dose aspirin in women with recurrent miscarriage. Blood2010;115(21):4162‐7. ">Clark 2010</a>; <a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a>; <a href="./references#CD004734-bbs2-0004" title="FawzyM , ShokeirT , El‐TatongyM , WardaO , El‐RefaieyAA , MosbahA . Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo‐controlled study. Archives of Gynecology and Obstetrics2008;278(1):33‐8. ">Fawzy 2008</a>; <a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a><a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>; <a href="./references#CD004734-bbs2-0007" title="MartinelliI . Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial. Pathophysiology of Haemostasis and Thrombosis2010;37 Suppl 1:A3. MartinelliI , RuggenentiP , CetinI , PardiG , PernaA , VerganiP , et al. Heparin in pregnant women with previous placenta‐mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood2012;119(14):3269‐75. [PUBMED: 22289887] ">Martinelli 2012</a>; <a href="./references#CD004734-bbs2-0008" title="TulppalaM , MarttunenM , Soderstrom‐AnttilaV , AilusK , PalosuoT , YlikorkalaO . Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(1):191. TulppalaM , MarttunenM , Soderstrom‐AnttilaV , FoudilaT , AilusK , PalosuoT , et al. Low‐dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(7):1567‐72. ">Tulppala 1997</a>; <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a>) in this review. In the studies <a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a> and <a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a>, full study populations were included. For the studies <a href="./references#CD004734-bbs2-0002" title="ClarkP . The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). ClarkP , WalkerID , LanghorneP , CrichtonL , ThomsonA , GreavesM , et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low‐molecular‐weight heparin and low‐dose aspirin in women with recurrent miscarriage. Blood2010;115(21):4162‐7. ">Clark 2010</a>; <a href="./references#CD004734-bbs2-0004" title="FawzyM , ShokeirT , El‐TatongyM , WardaO , El‐RefaieyAA , MosbahA . Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo‐controlled study. Archives of Gynecology and Obstetrics2008;278(1):33‐8. ">Fawzy 2008</a>; <a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a>; <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>; <a href="./references#CD004734-bbs2-0007" title="MartinelliI . Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial. Pathophysiology of Haemostasis and Thrombosis2010;37 Suppl 1:A3. MartinelliI , RuggenentiP , CetinI , PardiG , PernaA , VerganiP , et al. Heparin in pregnant women with previous placenta‐mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood2012;119(14):3269‐75. [PUBMED: 22289887] ">Martinelli 2012</a>; <a href="./references#CD004734-bbs2-0008" title="TulppalaM , MarttunenM , Soderstrom‐AnttilaV , AilusK , PalosuoT , YlikorkalaO . Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(1):191. TulppalaM , MarttunenM , Soderstrom‐AnttilaV , FoudilaT , AilusK , PalosuoT , et al. Low‐dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(7):1567‐72. ">Tulppala 1997</a>; and <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a>, we could not include full study populations, but had to extract data on the women fulfilling the inclusion criteria of the review. Reasons for including only part of the original study population are explained for each study. </p> <p><a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a> evaluated the effect of LMWH (enoxaparin 20 mg/day) in women with three or more consecutive first trimester miscarriages. Women were included if no risk factors for RM could be identified (women with inherited thrombophilia were excluded) and randomised to either treatment or no‐treatment (no placebo). Therapy was commenced once fetal viability was detected on ultrasound and continued until 34 weeks' gestation. The primary outcome was pregnancy loss and pregnancy complications, but live births could be calculated from the report and were confirmed by the study author. Of 350 women enrolled, 10 women (four (2.3%) and six (3.4%) in both arms) were lost to follow‐up, leaving 170 women in each study arm for analysis. Side effects of treatment were only reported for women randomised to treatment, not in those randomised to no‐treatment. </p> <p><a href="./references#CD004734-bbs2-0002" title="ClarkP . The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). ClarkP , WalkerID , LanghorneP , CrichtonL , ThomsonA , GreavesM , et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low‐molecular‐weight heparin and low‐dose aspirin in women with recurrent miscarriage. Blood2010;115(21):4162‐7. ">Clark 2010</a> studied the effect of LMWH (enoxaparin 40 mg/day) and aspirin (75 mg/day) from before seven weeks' gestation until 36 weeks' gestation on live birth in 296 women with RM, defined as a minimum of two consecutive early pregnancy losses (at or before 24 weeks' gestation). Intervention with LMWH and aspirin combined with intense pregnancy surveillance was compared with intense pregnancy surveillance without pharmacological intervention. Women were included upon a positive pregnancy test (before seven weeks' gestation). Investigations for uterine or chromosomal abnormalities and antiphospholipid syndrome were conducted only for women with three or more previous miscarriages. Women who were included because of two previous miscarriages were excluded from our analysis, because it could not be confirmed that previous miscarriages were 'unexplained'. The primary outcome measure in the study was live birth. Adverse events of intervention were reported, though could not be extracted for the women with three or more previous miscarriages. One‐hundred and twenty‐two women were included in the review (64 randomised to LMWH and aspirin versus 58 randomised to surveillance). </p> <p><a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a> evaluated the effect of LMWH compared with aspirin in 104 women with unexplained RM. RM was defined as three or more consecutive first trimester miscarriages or at least two consecutive second trimester miscarriages. The objective was to compare the effect of enoxaparin and aspirin on live birth rate. Women were only included if there was no apparent risk factors for the miscarriages and women with inherited thrombophilia were excluded. The treatment with enoxaparin (40 mg/day) or aspirin (100 mg/day) was started from the time of detection of a fetal heart beat at six to 12 weeks' gestation and continued until a gestational age of 37 weeks. Of the 107 included women, 54 received enoxaparin, 50 aspirin and three were lost to follow‐up. Besides the primary outcome measure of live birth, secondary outcomes like preterm delivery, intrauterine growth restriction, and pre‐eclampsia were reported. </p> <p><a href="./references#CD004734-bbs2-0004" title="FawzyM , ShokeirT , El‐TatongyM , WardaO , El‐RefaieyAA , MosbahA . Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo‐controlled study. Archives of Gynecology and Obstetrics2008;278(1):33‐8. ">Fawzy 2008</a> assessed the effect of LMWH (enoxaparin 20 mg/day) compared with combination treatment (oral prednisone and progesterone from the onset of pregnancy until 12 weeks of gestation and aspirin from the onset of pregnancy until 32 weeks of gestation) compared with placebo (for oral intervention) in women with three or more consecutive unexplained miscarriages (before 24 weeks' gestation) with the same partner. Women with inherited thrombophilia were excluded. From this study, we extracted data for the 107 women receiving enoxaparin or placebo. Of these women, 57 were assigned to enoxaparin and 50 to placebo. Treatment was started when a fetal pole was detected and continued until term. The primary outcome was live birth, but secondary outcomes such as obstetric complications and neonatal outcomes were also reported. </p> <p><a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a> evaluated the effect of LMWH or aspirin or a combination of these in 167 women with a history of two or more unexplained miscarriages before 12 weeks' gestation. Women with uterine or chromosomal abnormalities were excluded, but women with inherited thrombophilia or antiphospholipid syndrome were eligible. Women were randomised to LMWH (enoxaparin 40 mg/day from diagnosis of intrauterine pregnancy until delivery) or aspirin (100 mg/day from diagnosis of pregnancy until 32 weeks' gestation) or first aspirin (100 mg/day from diagnosis of pregnancy), which was replaced by LMWH at 32 weeks' gestation (enoxaparin 40 mg/day continued until delivery). For this analysis, we included only data from women without antiphospholipid antibodies randomised to either LMWH (n = 40) or aspirin (n = 46). The primary outcome of the study was live birth, and no secondary outcome measures were reported. </p> <p><a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a> evaluated the effect of open label LMWH (nadroparin 2850 IU/day) combined with aspirin (80 mg/day) or aspirin only (80 mg/day) compared with placebo in 364 women with unexplained RM with or without inherited thrombophilia. Previous miscarriage was defined as pregnancy loss at a gestational age of 20 weeks or less. Women were included in the study if they were attempting to conceive or were less than six weeks pregnant. From this study, we extracted data of the 299 women who became pregnant (97 were assigned to aspirin plus nadroparin, 99 were assigned to aspirin only and 103 were assigned to placebo). LMWH was initiated when a viable intrauterine pregnancy was confirmed on ultrasonography at six weeks' gestation until the start of labour. Aspirin or placebo was started at randomisation and continued until a gestational age of 36 weeks. The primary outcome was live birth, and secondary outcomes were adverse pregnancy outcomes and maternal adverse events. Secondary outcomes such as obstetric complications and neonatal events were evaluated for 200 women with ongoing pregnancy beyond 12 weeks of gestation. </p> <p><a href="./references#CD004734-bbs2-0007" title="MartinelliI . Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial. Pathophysiology of Haemostasis and Thrombosis2010;37 Suppl 1:A3. MartinelliI , RuggenentiP , CetinI , PardiG , PernaA , VerganiP , et al. Heparin in pregnant women with previous placenta‐mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood2012;119(14):3269‐75. [PUBMED: 22289887] ">Martinelli 2012</a> evaluated the effect of open label LMWH (nadroparin 3800 IU/day), compared with no treatment in 135 women with previous placenta‐mediated pregnancy complications. Women with antiphospholipid syndrome, uterine anomalies or abnormal karyotype were excluded from the study. Inherited thrombophilia was not an exclusion criterion. LMWH was compared with medical surveillance only and treatment was initiated upon randomisation and continued until delivery. Randomisation was performed around the 12th week of gestation, after pregnancy was confirmed on ultrasonography. The primary outcome of the study was a composite outcome of several pregnancy complications. For this review we included data of six women, who had a history of two or more unexplained miscarriages up to 24 weeks' gestation. </p> <p><a href="./references#CD004734-bbs2-0008" title="TulppalaM , MarttunenM , Soderstrom‐AnttilaV , AilusK , PalosuoT , YlikorkalaO . Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(1):191. TulppalaM , MarttunenM , Soderstrom‐AnttilaV , FoudilaT , AilusK , PalosuoT , et al. Low‐dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(7):1567‐72. ">Tulppala 1997</a> evaluated the effect of aspirin (50 mg/day) on live birth rate in 66 pregnant women with preceding RM with or without detectable anticardiolipin antibodies and no other apparent risk factors for their previous miscarriages. RM was defined as three or more consecutive miscarriages (occurring before 22 weeks of gestational age). Aspirin was compared with placebo, and medication was started as soon as a home urinary pregnancy test became positive and continued until delivery. From this study, we extracted data for 54 women who were negative for anticardiolipin antibodies. Of these, 27 were assigned to aspirin and 27 to placebo. Secondary outcomes, such as preterm delivery, obstetric complications, and bleeding rate could not be extracted separately for the group of women with negative anticardiolipin antibodies. </p> <p><a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a> evaluated the effect of LMWH (enoxaparin 40 mg/day) plus oral placebo (n = 68) compared with LMWH (enoxaparin 40 mg/day) plus aspirin (100 mg/day) (n = 63), compared with aspirin only (100 mg/day) (n = 76) in women with unexplained RM with or without inherited thrombophilia. RM was defined as three or more consecutive first trimester miscarriages, two or more second trimester miscarriages or one third trimester fetal loss combined with at least one first trimester miscarriage. Treatment was initiated upon randomisation (before seven weeks' gestation); aspirin and placebo were discontinued at 36 weeks' gestation whereas enoxaparin was continued until the first signs of labour. The primary outcome was live birth and secondary outcomes were adverse pregnancy outcomes and bleeding. Premature delivery, obstetrical complications and congenital malformations were reported only for women who had live birth. Study authors stated that only one woman was included in the study because of RM based on one fetal loss before, and two fetal losses after 24 weeks' gestation; her data were excluded from this review. Furthermore, data of 10 women (allocated to enoxaparin plus placebo (n = 3, one live birth), enoxaparin plus aspirin (n = 2, one live birth), aspirin only (n = 5, four live births)) were excluded because of the presence of Beta‐2 glycoprotein antibodies. One‐hundred and ninety‐six women were included in this trial. </p> <p>As can be noted, no study compared the same treatment regimen. Studies compared different doses of LMWH and aspirin or combinations of these, and treatment was started at various gestational ages. As described in the Methods section, we pooled data based on type of intervention, but irrespective of the dose of LMWH or aspirin. Only studies in which the investigational treatment was started at a maximum of 12 weeks' gestation and continued beyond 32 weeks' gestation were included. </p> </section> <section id="CD004734-sec-0072"> <h4 class="title">Excluded studies</h4> <p>Overall, we excluded 22 studies from the review. We have provided the reasons for exclusion in the <a href="./references#CD004734-sec-0108" title="">Characteristics of excluded studies</a> table. </p> <p>Three studies are only available in abstract form (<a href="./references#CD004734-bbs2-0032" title="Abou‐NassarK , KovacsMJ , KahnSR , WellsP , DoucetteS , RamsayT , et al. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial. Thrombosis and Haemostasis2007;98(1):163‐71. Abou‐NassarK , RodgerM , KovacsMJ , DoucetteS , TimR , KahnS , et al. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomised trial. Blood2006;108(11 Pt 1):262. RodgerM , HagueWM , KingdomJ , KahnSR , KarovitchA , WellsPS , et al. The Thrombophilia in Pregnancy Prophylaxis Study (TIPPS): a multi‐national randomized trial of dalteparin vs. no dalteparin to prevent pregnancy complications in pregnant thrombophilic women. Journal of Thrombosis and Haemostasis2013;11(Suppl 2):78. RodgerMA . TIPPS: Thrombophilia in pregnancy prophylaxis study. ClinicalTrials.gov (accessed 21 May 2013). NCT00967382 2009. RodgerMA , KahnS , CranneyA , HodsonA , KovacsM , ClementAM , et al. Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD) [abstract]. Hypertension in Pregnancy2006;25(Suppl 1):8. RodgerMA , KahnSR , CranneyA , HodsmanA , KovacsMJ , ClementAM , et al. Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. Journal of Thrombosis and Haemostasis2007;5(8):1600‐6. RodgerMA , Lazo‐LangnerA , KahnS , KovacsM , RobinsonS , BlosteinM , et al. Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD substudy. Blood2005;106(11):Abstract no 548. RodgersM . Thrombophilia in pregnancy prophylaxis study (TIPPS). Ottawa Health Research Institute (http://www.ohri.ca) (accessed 17 July 2002). ">Rodger 2009</a>; <a href="./references#CD004734-bbs2-0033" title="SalmanSA , ShaabanOM , ZahranKM , FathallaMM , AnanMA . Low molecular weight heparin (LMWH) for treatment of recurrent miscarriage negatively tested for anti phospholipid antibodies: A randomized controlled trial. Fertility and Sterility2012;98(3 Suppl 1):S191. ">Salman 2012</a>; <a href="./references#CD004734-bbs2-0034" title="KaminG , RogenhoferN , PildnerV , SteinbergS , NeuhofferA , SeegerS , et al. Therapy with dalteparin for habitual abortion ‐ presentation of the ETHiG II‐Studie [Therapie mit Dalteparin bei habitueller Abortneigung ‐ Vorstellung der ETHiG II‐Studie]. Geburtshilfe und Frauenheilkunde2008;68:S51. SchleussnerE . Effectiveness of dalteparin therapy as intervention in recurrent pregnancy loss. http://controlled‐trials.com (accessed 15.02.2007). SchleussnerE , BohlmannM , KaminG , RogenhoferN , SeegerS , TothB . Low molecular weight heparin for the prevention of habitual abortion ‐ introduction of the multicentre study EThIG2 and discussion of the current data [Niedermolekulares heparin zur pravention habitueller aborte ‐ vorstellung der multizentrischen EThIG2‐studie und diskussion der aktuellen datenlage]. Archives of Gynecology and Obstetrics2012;286(Suppl 1):S220. SchleussnerE , KaminG , SeeligerG , RogenhoferN , TothB . Low‐molecular‐weight heparin in recurrent pregnancy loss‐Results of the ETHIG II study. Thrombosis Research2013;131(Suppl 1):S73. ">Schleussner 2013</a>) and we are awaiting the full study report, see <a href="./references#CD004734-sec-0109" title="">Characteristics of studies awaiting classification</a>. </p> </section> </section> <section id="CD004734-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p>Details for the included studies are shown in the <a href="./references#CD004734-sec-0107" title="">Characteristics of included studies</a> and in <a href="#CD004734-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD004734-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004734-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>The studies by <a href="./references#CD004734-bbs2-0002" title="ClarkP . The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). ClarkP , WalkerID , LanghorneP , CrichtonL , ThomsonA , GreavesM , et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low‐molecular‐weight heparin and low‐dose aspirin in women with recurrent miscarriage. Blood2010;115(21):4162‐7. ">Clark 2010</a>; <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>; <a href="./references#CD004734-bbs2-0007" title="MartinelliI . Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial. Pathophysiology of Haemostasis and Thrombosis2010;37 Suppl 1:A3. MartinelliI , RuggenentiP , CetinI , PardiG , PernaA , VerganiP , et al. Heparin in pregnant women with previous placenta‐mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood2012;119(14):3269‐75. [PUBMED: 22289887] ">Martinelli 2012</a> and <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a> were considered to be at low risk of bias for all assessed criteria. </p> <section id="CD004734-sec-0074"> <h4 class="title">Allocation</h4> <p>Procedures for adequate allocation concealment were well described in the studies by <a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a>; <a href="./references#CD004734-bbs2-0002" title="ClarkP . The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). ClarkP , WalkerID , LanghorneP , CrichtonL , ThomsonA , GreavesM , et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low‐molecular‐weight heparin and low‐dose aspirin in women with recurrent miscarriage. Blood2010;115(21):4162‐7. ">Clark 2010</a>; <a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a>; <a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a>; <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>; <a href="./references#CD004734-bbs2-0007" title="MartinelliI . Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial. Pathophysiology of Haemostasis and Thrombosis2010;37 Suppl 1:A3. MartinelliI , RuggenentiP , CetinI , PardiG , PernaA , VerganiP , et al. Heparin in pregnant women with previous placenta‐mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood2012;119(14):3269‐75. [PUBMED: 22289887] ">Martinelli 2012</a>; and <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a>. Dr Tulppala provided information about allocation in her study (<a href="./references#CD004734-bbs2-0008" title="TulppalaM , MarttunenM , Soderstrom‐AnttilaV , AilusK , PalosuoT , YlikorkalaO . Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(1):191. TulppalaM , MarttunenM , Soderstrom‐AnttilaV , FoudilaT , AilusK , PalosuoT , et al. Low‐dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(7):1567‐72. ">Tulppala 1997</a>), which was then judged to be at low risk of bias. Based on the report and information provided by Dr Fawzy regarding treatment allocation, we judged this study (<a href="./references#CD004734-bbs2-0004" title="FawzyM , ShokeirT , El‐TatongyM , WardaO , El‐RefaieyAA , MosbahA . Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo‐controlled study. Archives of Gynecology and Obstetrics2008;278(1):33‐8. ">Fawzy 2008</a>) to be at high risk of selection bias. </p> </section> <section id="CD004734-sec-0075"> <h4 class="title">Blinding</h4> <p>As explained in the methods sections, performance bias and detection bias were not included as criterion for quality. </p> </section> <section id="CD004734-sec-0076"> <h4 class="title">Incomplete outcome data</h4> <p>The study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a> was analysed on intention‐to‐treat basis, including women lost to follow‐up. Other studies reported outcomes for randomised women minus any participants whose outcomes were missing. Numbers of women lost to follow‐up were small and well balanced for each group and not enough to have a clinically relevant impact on the intervention effect estimate. All studies were therefore considered to be at low risk of attrition bias. </p> </section> <section id="CD004734-sec-0077"> <h4 class="title">Selective reporting</h4> <p>Assessment of reporting bias was impossible for <a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a>; and <a href="./references#CD004734-bbs2-0008" title="TulppalaM , MarttunenM , Soderstrom‐AnttilaV , AilusK , PalosuoT , YlikorkalaO . Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(1):191. TulppalaM , MarttunenM , Soderstrom‐AnttilaV , FoudilaT , AilusK , PalosuoT , et al. Low‐dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(7):1567‐72. ">Tulppala 1997</a> as trial registration was not operative at time of inclusion.The studies by <a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a>, <a href="./references#CD004734-bbs2-0004" title="FawzyM , ShokeirT , El‐TatongyM , WardaO , El‐RefaieyAA , MosbahA . Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo‐controlled study. Archives of Gynecology and Obstetrics2008;278(1):33‐8. ">Fawzy 2008</a> and <a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a> were considered to be at high risk of bias because they were not registered in a prospective trial register. Other studies were considered to be at low risk of reporting bias. </p> </section> <section id="CD004734-sec-0078"> <h4 class="title">Other potential sources of bias</h4> <p>There were inconsistencies in the report by <a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a>, and the report by <a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a> provided no baseline table, which made it impossible to determine whether prognostic factors were evenly distributed between groups. </p> </section> </section> <section id="CD004734-sec-0079"> <h3 class="title" id="CD004734-sec-0079">Effects of interventions</h3> <p>We included nine studies, involving 1228 participants, in this review. Since treatment regimens varied among included studies, pooled analysis could not include more than three studies, except for when LMWH with or without aspirin was compared to no treatment. Only one study (<a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>) included women who used anticoagulants preconceptionally. This yielded insufficient data to perform the planned subgroup analysis for pre‐ and periconceptional anticoagulant use. Where studies reported pregnancy complications, different denominators (e.g. all pregnant women, only ongoing pregnancies, only women with live births) were used in different studies and results could not be pooled. This is explained for the comparisons of treatment concerned. </p> <section id="CD004734-sec-0080"> <h4 class="title">Aspirin versus no treatment</h4> <p>Pooled analysis from 256 patients showed that compared to placebo, aspirin did not increase live birth (risk ratio (RR) 0.94, 95% confidence interval (CI) 0.80 to 1.11), <a href="./references#CD004734-fig-0002" title="">Analysis 1.1</a>, (<a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>; <a href="./references#CD004734-bbs2-0008" title="TulppalaM , MarttunenM , Soderstrom‐AnttilaV , AilusK , PalosuoT , YlikorkalaO . Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(1):191. TulppalaM , MarttunenM , Soderstrom‐AnttilaV , FoudilaT , AilusK , PalosuoT , et al. Low‐dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(7):1567‐72. ">Tulppala 1997</a>). Subgroup analyses for the outcome live birth for women with no previous live births (RR 0.93, 95% CI 0.72 to 1.21), inherited thrombophilia (RR 1.08, 95% CI 0.63 to 1.85) or more than two miscarriages (RR 0.95, 95% CI 0.70 to 1.28) could only be performed for the study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a> and also showed no effect of treatment. </p> <p>Secondary outcomes were not reported by <a href="./references#CD004734-bbs2-0008" title="TulppalaM , MarttunenM , Soderstrom‐AnttilaV , AilusK , PalosuoT , YlikorkalaO . Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(1):191. TulppalaM , MarttunenM , Soderstrom‐AnttilaV , FoudilaT , AilusK , PalosuoT , et al. Low‐dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction1997;12(7):1567‐72. ">Tulppala 1997</a>. Preterm delivery, obstetric complications and congenital malformations as reported by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a> for women with ongoing pregnancies beyond 12 weeks' gestation did not differ between the two groups. Bleeding as a side effect from treatment (mainly nose or gum bleeds or haematomas) was reported for 30% of women receiving aspirin and for 27% women receiving placebo (RR 1.11, 95% CI 0.72 to 1.72, <a href="./references#CD004734-fig-0010" title="">Analysis 1.9</a>). It should be noted that bleeding was reported for all women included in the study, including women who did not become pregnant during the course of the study. </p> </section> <section id="CD004734-sec-0081"> <h4 class="title">LMWH versus aspirin  </h4> <p>Three studies compared enoxaparin with aspirin (<a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a>; <a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a>; <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a>). Pooled analysis (n = 325) showed an average RR of live birth for women treated with aspirin of 1.16 (95% CI 0.93 to 1.45; Heterogeneity: Tau² = 0.03; I² = 67%, <a href="./references#CD004734-fig-0021" title="">Analysis 3.1</a>). Due to substantial statistical heterogeneity being detected, we used random‐effects meta‐analysis in <a href="./references#CD004734-fig-0021" title="">Analysis 3.1</a>. After excluding the study by <a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a> at high risk of bias, both groups had similar live birth rates, 76% in the enoxaparin group and 70% in the aspirin group (RR 1.08, 95% CI 0.93 to 1.26, <a href="./references#CD004734-fig-0012" title="">Analysis 2.1</a>). In the subgroup of women with no previous live births, the RR of live birth with LMWH was 1.24 (95% CI 1.02 to 1.49) compared to aspirin. </p> <p>The study by <a href="./references#CD004734-bbs2-0005" title="ChistoliniA , TorelliF , GiancottiA , PignoloniP , MutoB , CosimoC , et al. Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]. Hematology Journal2006;91(Suppl 1):146. GiancottiA , TorreRL , SpagnuoloA , D'AmbrosioV , CerekjaA , PiazzeJ , et al. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(7):1191‐4. [PUBMED: 21988715] ">Giancotti 2012</a> reported no secondary outcome measures. Results of secondary outcome measures for the studies by <a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a> and <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a> could not be pooled, as both studies used different denominators (i.e. all pregnancies in the study by <a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a> and only women with live birth in the study by <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a>). In the individual studies, the number of preterm deliveries (before 37 weeks), cases of intrauterine growth restriction, pre‐eclampsia and congenital malformations did not differ between the two groups, Bleeding complications did not differ between the two groups in both studies, though results of bleeding were very different; 0% versus 0.04% in the study by <a href="./references#CD004734-bbs2-0003" title="DolitzkyM , InbalA , SegalY , WeissA , BrennerB , CarpH . A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility2006;86(2):362‐6. ">Dolitzky 2006</a> and 49% versus 50% in the study by <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a> in women treated with LMWH versus aspirin respectively. </p> </section> <section id="CD004734-sec-0082"> <h4 class="title">LMWH versus no treatment</h4> <p>The effect of LMWH was evaluated in three studies (<a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a>; <a href="./references#CD004734-bbs2-0004" title="FawzyM , ShokeirT , El‐TatongyM , WardaO , El‐RefaieyAA , MosbahA . Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo‐controlled study. Archives of Gynecology and Obstetrics2008;278(1):33‐8. ">Fawzy 2008</a>; <a href="./references#CD004734-bbs2-0007" title="MartinelliI . Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial. Pathophysiology of Haemostasis and Thrombosis2010;37 Suppl 1:A3. MartinelliI , RuggenentiP , CetinI , PardiG , PernaA , VerganiP , et al. Heparin in pregnant women with previous placenta‐mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood2012;119(14):3269‐75. [PUBMED: 22289887] ">Martinelli 2012</a>). Pooled analysis (n = 453) showed an average RR of live birth for women treated with LMWH of 1.23 (95% CI 0.84 to 1.81; Heterogeneity: Tau² = 0.09; I² = 80%, <a href="./references#CD004734-fig-0023" title="">Analysis 5.1</a>). Due to substantial statistical heterogeneity being detected, we used random‐effects meta‐analysis in <a href="./references#CD004734-fig-0023" title="">Analysis 5.1</a>. When excluding studies at high risk of bias, only the data of six women included in the study by <a href="./references#CD004734-bbs2-0007" title="MartinelliI . Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial. Pathophysiology of Haemostasis and Thrombosis2010;37 Suppl 1:A3. MartinelliI , RuggenentiP , CetinI , PardiG , PernaA , VerganiP , et al. Heparin in pregnant women with previous placenta‐mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood2012;119(14):3269‐75. [PUBMED: 22289887] ">Martinelli 2012</a> could be analysed. Of these six women, four were randomised to LMWH and two to no treatment and all six had a live birth during the study (<a href="./references#CD004734-fig-0022" title="">Analysis 4.1</a>). Secondary outcomes were only reported by studies at high risk of bias, and could not be pooled due to a difference in denominators (pregnancies continued beyond 21 weeks in the study by <a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a> and all pregnancies in the study by <a href="./references#CD004734-bbs2-0004" title="FawzyM , ShokeirT , El‐TatongyM , WardaO , El‐RefaieyAA , MosbahA . Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo‐controlled study. Archives of Gynecology and Obstetrics2008;278(1):33‐8. ">Fawzy 2008</a>). No difference between treatment groups were found in individual studies for pregnancy complications, bleeding or thromboembolic events. The study by <a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a> reported that 22% of women treated with LMWH experienced symptoms of bleeding and 30% local skin reactions. </p> </section> <section id="CD004734-sec-0083"> <h4 class="title">LMWH and aspirin versus no treatment</h4> <p>The effect of LMWH and aspirin on live birth compared to no treatment or placebo was evaluated in two studies (n = 322) (<a href="./references#CD004734-bbs2-0002" title="ClarkP . The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). ClarkP , WalkerID , LanghorneP , CrichtonL , ThomsonA , GreavesM , et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low‐molecular‐weight heparin and low‐dose aspirin in women with recurrent miscarriage. Blood2010;115(21):4162‐7. ">Clark 2010</a>; <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>). Live birth occurred as often in women receiving LMWH and aspirin (n = 161) as in women who received no treatment (n = 161) (RR for women who received LMWH and aspirin 1.01, 95% CI 0.87 to 1.16), <a href="./references#CD004734-fig-0030" title="">Analysis 6.1</a>). Subgroup analyses for the outcome live birth could only be performed for the study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>. For women with no previous live births (RR 1.05, 95% CI 0.83 to 1.34), or more than two miscarriages ( RR 1.00, 95% CI 0.75 to 1.33) no effect of treatment was found. Data of women with inherited thrombophilia suggested a potential benefit in these women when treated with LMWH and aspirin, but the subgroup was underpowered for firm conclusions (RR 1.25, 95% CI 0.74 to 2.12). </p> <p>Data of secondary outcomes were not available for the study by <a href="./references#CD004734-bbs2-0002" title="ClarkP . The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). ClarkP , WalkerID , LanghorneP , CrichtonL , ThomsonA , GreavesM , et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low‐molecular‐weight heparin and low‐dose aspirin in women with recurrent miscarriage. Blood2010;115(21):4162‐7. ">Clark 2010</a> and are therefore only described for the study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>. The occurrence of obstetric complications did not differ between the two study arms. Maternal bleeding (mainly nose or gum bleeds or haematomas) occurred significantly more frequently in women who received treatment; resulting in a RR of any bleeding of 2.28 (95% CI 1.60 to 3.24, <a href="./references#CD004734-fig-0038" title="">Analysis 6.9</a>). Pain, itching and swelling at injection site was reported by 51% of the women treated with LMWH and aspirin. </p> </section> <section id="CD004734-sec-0084"> <h4 class="title">LMWH and aspirin versus aspirin</h4> <p>In the studies by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a> and <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a> the effect of LMWH and aspirin was compared with aspirin only (n = 327). Live birth did not differ significantly between both groups; 68% and 61% respectively (RR 1.11, 95% CI 0.94 to 1.30, <a href="./references#CD004734-fig-0040" title="">Analysis 7.1</a>). Subgroup analyses for the outcome live birth in women with either no previous live births, inherited thrombophilia or more than two previous miscarriages (study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a> only) also showed no effect of treatment. </p> <p>Again, results for secondary outcome measures could not be pooled because different denominators (ongoing pregnancies in the study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a> and pregnancies that ended in live birth in the study by <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a>) were used. The incidence of preterm delivery, pre‐eclampsia, intrauterine growth restriction (IUGR) and congenital malformations was similar in both groups in the individual studies. A significant difference was seen in bleeding (mainly nose or gum bleeds or haematomas) between the two groups, favouring treatment with aspirin only (RR for bleeding in women treated with LMWH and aspirin 2.04, 95% CI 1.46 to 2.86, <a href="./references#CD004734-fig-0048" title="">Analysis 7.9</a>), in the study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>, 62% of women treated with LMWH and aspirin experienced bleeding compared to 30% in women treated with aspirin only. In the study by <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a>, bleeding (reported as first trimester, second/third trimester bleeding or postpartum haemorrhage) was reported more often in women treated with aspirin (38% in women treated with LMWH and aspirin and 50% in women treated with aspirin only), though this difference was not significant (RR 0.75, 95% CI 0.45 to 1.24, <a href="./references#CD004734-fig-0048" title="">Analysis 7.9</a>). </p> </section> <section id="CD004734-sec-0085"> <h4 class="title">LMWH with aspirin versus LMWH</h4> <p>One study evaluated the effect of LMWH and aspirin (n = 61) in comparison with LMWH only (n = 65) (<a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a>). Neither live birth, nor any of the secondary outcomes including bleeding were different between the two groups (RR of live birth in women treated with LMWH plus aspirin 0.91, 95% CI 0.72 to 1.15, <a href="./references#CD004734-fig-0051" title="">Analysis 8.1</a>). Subgroup analyses in women with inherited thrombophilia or no previous live birth were small and showed no benefit of one treatment over the other. </p> </section> <section id="CD004734-sec-0086"> <h4 class="title">LMWH with or without aspirin versus no treatment</h4> <p>Results of studies were combined, to evaluate the effect of LMWH with or without aspirin on the chance of live birth. Pooled results from 793 patients of five studies (<a href="./references#CD004734-bbs2-0001" title="BadawyAM , KhiaryM , SherifLS , HassanM , RagabA , AbdelallI . Low‐molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. Journal of Obstetrics and Gynaecology2008;28(3):280‐4. ">Badawy 2008</a>; <a href="./references#CD004734-bbs2-0002" title="ClarkP . The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). ClarkP , WalkerID , LanghorneP , CrichtonL , ThomsonA , GreavesM , et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low‐molecular‐weight heparin and low‐dose aspirin in women with recurrent miscarriage. Blood2010;115(21):4162‐7. ">Clark 2010</a>; <a href="./references#CD004734-bbs2-0004" title="FawzyM , ShokeirT , El‐TatongyM , WardaO , El‐RefaieyAA , MosbahA . Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo‐controlled study. Archives of Gynecology and Obstetrics2008;278(1):33‐8. ">Fawzy 2008</a>; <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>; <a href="./references#CD004734-bbs2-0007" title="MartinelliI . Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial. Pathophysiology of Haemostasis and Thrombosis2010;37 Suppl 1:A3. MartinelliI , RuggenentiP , CetinI , PardiG , PernaA , VerganiP , et al. Heparin in pregnant women with previous placenta‐mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood2012;119(14):3269‐75. [PUBMED: 22289887] ">Martinelli 2012</a>) showed no effect of treatment (RR 1.07, 95% CI 0.99 to 1.15, <a href="./references#CD004734-fig-0057" title="">Analysis 9.1</a>). After excluding studies at high risk of bias the point estimate shifted towards 1 and no effect of treatment was observed (n = 324, RR for live birth in women treated with LMWH 0.98, 95% CI 0.85 to 1.12, <a href="./references#CD004734-fig-0058" title="">Analysis 10.1</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004734-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004734-sec-0087"></div> <p>Since the last update of this review (<a href="./references#CD004734-bbs2-0092" title="KaandorpS , DiNisioM , GoddijnM , MiddeldorpS . Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD004734.pub3] ">Kaandorp 2009</a>), seven randomised controlled trials on the efficacy and safety of aspirin and heparin in women with a history of at least two miscarriages without apparent risk factors other than inherited thrombophilia were published, but the number of studies on this topic remains limited. Although in total nine studies were included, three studies were considered to be at high risk of bias and from one study, data of only six women could be included. Different treatment doses of anticoagulants compared, prescribed for different time periods, resulted in maximally three studies per comparison that could be pooled and only three of seven comparisons included a placebo‐ or no treatment‐arm. </p> <p>Irrespective of the type of or combinations of anticoagulants used, no benefit of anticoagulant treatment for live birth was found. </p> <p>Data for subgroup analyses were scarce. Subgroup analyses in women with more than two previous miscarriages showed no effect of treatment, regardless which treatment regimens were compared. A trend towards a significant effect from LMWH when compared to aspirin (risk ratio (RR) of live birth 1.21, 95% confidence interval (CI) 0.79 to 1.87) and of LMWH and aspirin when compared to no treatment (RR of live birth 1.25, 95% CI 0.74 to 2.12) was observed in women with inherited thrombophilia but the subgroups were underpowered for firm conclusions. As the clinical question of efficacy of anticoagulants for women with recurrent miscarriage (RM) and inherited thrombophilia remains relevant, randomised controlled trials focussing on women with inherited thrombophilia only are urgently needed. </p> <p>In subgroup analyses of women with no previous live birth, a beneficial effect of LMWH over aspirin was found in pooled analyses of two studies (n = 112, RR 1.24, 95% CI 1.02 to 1.49). Some evidence of a similar trend toward a beneficial effect for LMWH versus LMWH and aspirin was observed in a small subgroup in one study (n = 72, RR of live birth in women treated with LMWH and aspirin 0.77, 95% CI 0.59 to 1.02). In comparisons of LMWH and aspirin with either no treatment or with aspirin, no beneficial effect of LMWH and aspirin was found for women with no previous live birth. All subgroup analyses in women with no previous live birth were limited due to small numbers. </p> <p>Reporting of secondary outcomes varied widely among studies. In studies that reported pregnancy complications, different denominators (e.g. all pregnant women, only ongoing pregnancies, only live births) were used and results could not be pooled. In the individual studies, no effect of treatment on any pregnancy complication was found. Especially reporting of side effects of treatment, such as bleeding and local skin reactions (for LMWH) was inconsistent. The risk of bleeding (mainly nose or gum bleeds or haematomas) was more than two‐fold increased in women treated with LMWH and aspirin, compared to either aspirin only or no treatment in the study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a>. This was not confirmed in the study by <a href="./references#CD004734-bbs2-0009" title="VisserJ , UlanderV , BloemenkampK , KaajaR . A randomised controlled multicenter study: the effect of enoxaparin and/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX‐study. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S371. VisserJ , UlanderV‐M , HelmerhorstFM , LampinenK , Morin‐PapunenL , BloemenkampKWM , et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia ‐ HABENOX*: a randomised multicentre trial. Thrombosis and Haemostasis2011;105(2):295‐301. ">Visser 2011</a> (reporting first‐trimester, second/third trimester bleeding and postpartum haemorrhage, results could not be pooled). Local skin reactions to administered LMWH were not reported in several studies, whereas 50% of women treated with LMWH and aspirin in the study by <a href="./references#CD004734-bbs2-0006" title="KaandorpSP , GoddijnM , van derPostJA , HuttenBA , VerhoeveHR , HamulyakK , et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. New England Journal of Medicine2010;362(17):1586‐96. MiddeldorpS . Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra‐uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005). ">Kaandorp 2010</a> reported these side effects. </p> <p>Besides the limited number of studies on this topic, we must appreciate the heterogeneity between studies. Study designs vary regarding dose, duration and type of treatment, blinding, reporting of secondary outcomes and study quality. Furthermore, lack of a no‐treatment (or placebo) arm in some studies impedes assessing a risk‐benefit ratio for the individual interventions. </p> <p>Although in approximately half of women with RM risk factors can be identified, in 50% this remains unexplained. One could argue that the group of women with unexplained RM is in fact a heterogeneous collection of subgroups of women with as yet unidentified risk factors. Once identified, these risk factors may render them ineligible for the study. For this review, we have studied women with unexplained RM (with or without inherited thrombophilia) as one group and where possible we performed a subgroup analysis in women with inherited thrombophilia. Obvious risk factors of RM such as antiphospholipid syndrome, abnormal parental karyotypes and uterine abnormalities were exclusion criteria. This approach yields results that can be applied to all women with unexplained RM, with or without inherited thrombophilia. If future research leads to the identification of other risk factors for RM, therapeutic options for that newly identified subgroup will have to be considered. </p> <p>Our review of currently available (though limited) data, does not support the use of anticoagulants heparin, LMWH and aspirin, or combinations of these, for women with unexplained RM with or without inherited thrombophilia. Included studies were not sufficiently powered to evaluate an effect of heparin, LMWH or aspirin or combinations in women with confirmed inherited thrombophilia and unexplained recurrent miscarriage. Large randomised controlled trials assessing this subgroup are urgently needed, but until results are available, anticoagulants in these women are also not recommended in this setting. </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD004734-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004734-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/full#CD004734-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 1 Live birth." data-id="CD004734-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 1 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 2 Preterm delivery &lt; 37 weeks." data-id="CD004734-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 2 Preterm delivery &lt; 37 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 3 Preterm delivery 24‐28 weeks." data-id="CD004734-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 3 Preterm delivery 24‐28 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 4 Preterm delivery 28‐32 weeks." data-id="CD004734-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 4 Preterm delivery 28‐32 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 5 Preterm delivery 32‐37 weeks." data-id="CD004734-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 5 Preterm delivery 32‐37 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 6 Obstetric complications; pre‐eclampsia." data-id="CD004734-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 6 Obstetric complications; pre‐eclampsia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 7 Obstetric complications; IUGR." data-id="CD004734-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 7 Obstetric complications; IUGR.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 8 Congenital malformations." data-id="CD004734-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 8 Congenital malformations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 9 Side effects; any bleeding." data-id="CD004734-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 9 Side effects; any bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Aspirin versus no treatment, Outcome 10 HIT/thrombocytopenia." data-id="CD004734-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Aspirin versus no treatment, Outcome 10 HIT/thrombocytopenia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 1 Live birth." data-id="CD004734-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 1 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 2 Preterm delivery &lt; 37 weeks." data-id="CD004734-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 2 Preterm delivery &lt; 37 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 3 Preterm delivery 24‐28 weeks." data-id="CD004734-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 3 Preterm delivery 24‐28 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 4 Preterm delivery 28‐32 weeks." data-id="CD004734-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 4 Preterm delivery 28‐32 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 5 Preterm delivery 32‐37 weeks." data-id="CD004734-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 5 Preterm delivery 32‐37 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 6 Obstetric complications; pre‐eclampsia." data-id="CD004734-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 6 Obstetric complications; pre‐eclampsia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 7 Obstetric complications; IUGR." data-id="CD004734-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 7 Obstetric complications; IUGR.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 8 Obstetric complications; congenital malformations." data-id="CD004734-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 8 Obstetric complications; congenital malformations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH versus aspirin, Outcome 9 Side effects; any bleeding." data-id="CD004734-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 LMWH versus aspirin, Outcome 9 Side effects; any bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 LMWH versus aspirin including studies at high risk of bias, Outcome 1 Live birth." data-id="CD004734-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 LMWH versus aspirin including studies at high risk of bias, Outcome 1 Live birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 LMWH versus no treatment, Outcome 1 Live birth." data-id="CD004734-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 LMWH versus no treatment, Outcome 1 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 1 Live birth." data-id="CD004734-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 1 Live birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 2 Preterm delivery &lt; 37 weeks." data-id="CD004734-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 2 Preterm delivery &lt; 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 3 Obstetric complications; pre‐eclampsia." data-id="CD004734-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 3 Obstetric complications; pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 4 Obstetric complications; IUGR." data-id="CD004734-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 4 Obstetric complications; IUGR. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 5 Obstetric complications; congenital malformations." data-id="CD004734-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 5 Obstetric complications; congenital malformations. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 6 Side effects; any bleeding." data-id="CD004734-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 6 Side effects; any bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 7 Thromboembolic complications." data-id="CD004734-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 LMWH versus no treatment including studies at high risk of bias, Outcome 7 Thromboembolic complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 1 Live birth." data-id="CD004734-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 1 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 2 Preterm delivery &lt; 37 weeks." data-id="CD004734-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 2 Preterm delivery &lt; 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 3 Preterm delivery 24‐28 weeks." data-id="CD004734-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 3 Preterm delivery 24‐28 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 4 Preterm delivery 28‐32 weeks." data-id="CD004734-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 4 Preterm delivery 28‐32 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 5 Preterm delivery 32‐37 weeks." data-id="CD004734-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 5 Preterm delivery 32‐37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 6 Obstetric complications; pre‐eclampsia." data-id="CD004734-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 6 Obstetric complications; pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 7 Obstetric complications; IUGR." data-id="CD004734-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 7 Obstetric complications; IUGR. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 8 Congenital Malformations." data-id="CD004734-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 8 Congenital Malformations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 9 Side effects; any bleeding." data-id="CD004734-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 9 Side effects; any bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 LMWH and aspirin versus no treatment, Outcome 10 Side effects; pain/itching/swelling at injection site." data-id="CD004734-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 LMWH and aspirin versus no treatment, Outcome 10 Side effects; pain/itching/swelling at injection site. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 1 Live birth." data-id="CD004734-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 1 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 2 Preterm delivery &lt; 37 weeks." data-id="CD004734-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 2 Preterm delivery &lt; 37 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 3 Preterm delivery 24‐28 weeks." data-id="CD004734-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 3 Preterm delivery 24‐28 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 4 Preterm delivery; 28‐32 weeks." data-id="CD004734-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 4 Preterm delivery; 28‐32 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 5 Preterm delivery; 32‐37 weeks." data-id="CD004734-fig-0044" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 5 Preterm delivery; 32‐37 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 6 Obstetric complications; pre‐eclampsia." data-id="CD004734-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 6 Obstetric complications; pre‐eclampsia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 7 Obstetric complications; IUGR." data-id="CD004734-fig-0046" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 7 Obstetric complications; IUGR.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 8 Congenital malformations." data-id="CD004734-fig-0047" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 8 Congenital malformations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 9 Side effects; any bleeding." data-id="CD004734-fig-0048" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 9 Side effects; any bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 10 Side effects; pain/itching/swelling at injection site." data-id="CD004734-fig-0049" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.10</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 10 Side effects; pain/itching/swelling at injection site. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-007-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-007-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 LMWH and aspirin versus aspirin, Outcome 11 HIT/thrombocytopenia." data-id="CD004734-fig-0050" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.11</div> <div class="figure-caption"> <p>Comparison 7 LMWH and aspirin versus aspirin, Outcome 11 HIT/thrombocytopenia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-007-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 LMWH and aspirin versus LMWH, Outcome 1 Live birth." data-id="CD004734-fig-0051" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 LMWH and aspirin versus LMWH, Outcome 1 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 LMWH and aspirin versus LMWH, Outcome 2 Preterm delivery &lt; 37 weeks." data-id="CD004734-fig-0052" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 LMWH and aspirin versus LMWH, Outcome 2 Preterm delivery &lt; 37 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 LMWH and aspirin versus LMWH, Outcome 3 Obstetric complications; pre‐eclampsia." data-id="CD004734-fig-0053" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 LMWH and aspirin versus LMWH, Outcome 3 Obstetric complications; pre‐eclampsia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 LMWH and aspirin versus LMWH, Outcome 4 Obstetric complications; IUGR." data-id="CD004734-fig-0054" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 LMWH and aspirin versus LMWH, Outcome 4 Obstetric complications; IUGR.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 LMWH and aspirin versus LMWH, Outcome 5 Congenital malformations." data-id="CD004734-fig-0055" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 LMWH and aspirin versus LMWH, Outcome 5 Congenital malformations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 LMWH and aspirin versus LMWH, Outcome 6 Side effects; any bleeding." data-id="CD004734-fig-0056" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 LMWH and aspirin versus LMWH, Outcome 6 Side effects; any bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 LMWH with or without aspirin vs no treatment including studies at high risk of bias, Outcome 1 Live birth." data-id="CD004734-fig-0057" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 LMWH with or without aspirin vs no treatment including studies at high risk of bias, Outcome 1 Live birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004734-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/urn:x-wiley:14651858:media:CD004734:CD004734-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_t/tCD004734-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 LMWH with or without aspirin vs no treatment, Outcome 1 Live birth." data-id="CD004734-fig-0058" src="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 LMWH with or without aspirin vs no treatment, Outcome 1 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/media/CDSR/CD004734/image_n/nCD004734-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Aspirin versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Live birth in all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.80, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Live birth in women with no previous live birth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.72, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Live birth in women with inherited thrombophilia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.63, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Live birth in women with more than two previous miscarriages</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.70, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm delivery &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm delivery 24‐28 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Preterm delivery 28‐32 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Preterm delivery 32‐37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Obstetric complications; pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Obstetric complications; IUGR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Congenital malformations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Side effects; any bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 HIT/thrombocytopenia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Aspirin versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">LMWH versus aspirin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Live birth in all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.93, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Live birth in women with no previous live birth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.02, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Live birth in women with inherited thrombophilia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.79, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm delivery &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm delivery 24‐28 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Preterm delivery 28‐32 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Preterm delivery 32‐37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Obstetric complications; pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Obstetric complications; IUGR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Obstetric complications; congenital malformations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Side effects; any bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">LMWH versus aspirin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">LMWH versus aspirin including studies at high risk of bias</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.93, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">LMWH versus aspirin including studies at high risk of bias</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">LMWH versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.56, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">LMWH versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">LMWH versus no treatment including studies at high risk of bias</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.84, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm delivery &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Obstetric complications; pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Obstetric complications; IUGR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Obstetric complications; congenital malformations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Side effects; any bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Thromboembolic complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">LMWH versus no treatment including studies at high risk of bias</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">LMWH and aspirin versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Live birth in all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.87, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Live birth in women with no previous live birth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.83, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Live birth in women with inherited thrombophilia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.74, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Live birth in women with more than two previous miscarriages</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.75, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm delivery &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm delivery 24‐28 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Preterm delivery 28‐32 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Preterm delivery 32‐37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Obstetric complications; pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Obstetric complications; IUGR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Congenital Malformations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Side effects; any bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Side effects; pain/itching/swelling at injection site <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">LMWH and aspirin versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">LMWH and aspirin versus aspirin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Live birth in all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.94, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Live birth in women with no previous live birth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.88, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Live birth in women with inherited thrombophilia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.73, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Live birth in women with more than two previous miscarriages</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.78, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm delivery &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm delivery 24‐28 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Preterm delivery; 28‐32 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Preterm delivery; 32‐37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Obstetric complications; pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Obstetric complications; IUGR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Congenital malformations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Side effects; any bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Side effects; pain/itching/swelling at injection site <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 HIT/thrombocytopenia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">LMWH and aspirin versus aspirin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">LMWH and aspirin versus LMWH</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Live birth in all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.72, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Live birth in women with no previous live birth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.59, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Live birth in women with inherited thrombophilia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.48, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm delivery &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Obstetric complications; pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Obstetric complications; IUGR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Congenital malformations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Side effects; any bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">LMWH and aspirin versus LMWH</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">LMWH with or without aspirin vs no treatment including studies at high risk of bias</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>793</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.99, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">LMWH with or without aspirin vs no treatment including studies at high risk of bias</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004734-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">LMWH with or without aspirin vs no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.85, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">LMWH with or without aspirin vs no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004734.pub4/references#CD004734-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004734.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004734-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004734-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004734-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004734-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004734\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004734\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004734\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004734\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004734\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004734.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004734.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004734.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004734.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004734.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714498719"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004734.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714498723"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004734.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d70255e299377',t:'MTc0MDcxNDQ5OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 